Amisulpride
Amisulpride (trade name Solian) is an antipsychotic drug sold by Sanofi-Aventis. It is not approved for use in the United States, but is approved for use in Europe and Australia for the treatment of psychoses and schizophrenia. Additionally, it is approved in Italy for the treatment of dysthymia (under the brand name Deniban). Amisulpride is a selective dopamine antagonist.
| Catalog Number | T0811 |
| Alternative Name(s) | DAN 2163 |
| Research Area | Neuroscience|||GPCR/G Protein |
| Molecular Formula | C17H27N3O4S |
| CAS# | 71675-85-9 |
| Purity | 100.00% |
| SMILES | CCN1CCCC1CNC(=O)c1cc(c(N)cc1OC)S(=O)(=O)CC |
| Size | 100 mg |
| Supplier Page | https://www.targetmol.com/compound/Amisulpride |
| Additional Information | https://www.targetmol.com/datasheet/T0811 |